Venkata Lokesh Battula

11PUBLICATIONS
15CO-AUTHORS
Predictive and prognostic markersInstruments and techniquesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 17, 2025
GD3 synthase drives resistance to p53-induced apoptosis in breast cancer by modulating mitochondrial function.

Vivek Anand, Fouad El-Dana, Natalia Baran

|Jan 11, 2025
FT538, iPSC-derived NK cells, enhance AML cell killing when combined with chemotherapy.

Amanda Eckstrom, Anudishi Tyagi, Sajid Mahmood

|Feb 28, 2024
Gamma delta T cells in acute myeloid leukemia: biology and emerging therapeutic strategies.

Adishwar Rao, Akriti Agrawal, Gautam Borthakur

|Nov 25, 2023
TP-0184 inhibits FLT3/ACVR1 to overcome FLT3 inhibitor resistance and hinder AML growth synergistically with venetoclax.

Anudishi Tyagi, Appalaraju Jaggupilli, Stanley Ly

|Apr 02, 2022
Correction: Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia.

Qi Zhang, Bridget Riley-Gillis, Lina Han

|Mar 01, 2022
Evidence supporting a role for the immune checkpoint protein B7-H3 in NK cell-mediated cytotoxicity against AML.

Anudishi Tyagi, Stanley Ly, Fouad El-Dana

Pageof 2

Frequent Collaborators

5 joint publications

Michael Andreeff

3 joint publications

Natalia Baran

2 joint publications

Anthony Letai

2 joint publications

Stephen T Wong